SHSAX vs. FPHAX
Compare and contrast key facts about BlackRock Health Sciences Opportunities Portfolio (SHSAX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
SHSAX is managed by Blackrock. It was launched on Dec 20, 1999. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SHSAX or FPHAX.
Key characteristics
| SHSAX | FPHAX | |
|---|---|---|
| YTD Return | 9.04% | 18.95% |
| 1Y Return | 16.38% | 26.86% |
| 3Y Return (Ann) | -2.80% | 3.59% |
| 5Y Return (Ann) | 3.04% | 5.95% |
| 10Y Return (Ann) | 3.53% | 3.97% |
| Sharpe Ratio | 1.17 | 1.51 |
| Sortino Ratio | 1.53 | 2.17 |
| Omega Ratio | 1.23 | 1.26 |
| Calmar Ratio | 0.60 | 1.64 |
| Martin Ratio | 5.24 | 6.29 |
| Ulcer Index | 2.68% | 3.74% |
| Daily Std Dev | 12.02% | 15.53% |
| Max Drawdown | -39.26% | -37.34% |
| Current Drawdown | -10.97% | -11.24% |
Correlation
The correlation between SHSAX and FPHAX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
SHSAX vs. FPHAX - Performance Comparison
In the year-to-date period, SHSAX achieves a 9.04% return, which is significantly lower than FPHAX's 18.95% return. Over the past 10 years, SHSAX has underperformed FPHAX with an annualized return of 3.53%, while FPHAX has yielded a comparatively higher 3.97% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SHSAX vs. FPHAX - Expense Ratio Comparison
SHSAX has a 1.09% expense ratio, which is higher than FPHAX's 0.75% expense ratio.
Risk-Adjusted Performance
SHSAX vs. FPHAX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Opportunities Portfolio (SHSAX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SHSAX vs. FPHAX - Dividend Comparison
SHSAX's dividend yield for the trailing twelve months is around 0.24%, less than FPHAX's 0.72% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHSAX BlackRock Health Sciences Opportunities Portfolio | 0.24% | 0.26% | 0.34% | 0.00% | 0.00% | 0.30% | 0.11% | 0.00% | 0.00% | 1.38% | 0.04% | 0.08% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.72% | 0.63% | 1.33% | 1.17% | 1.31% | 1.31% | 1.44% | 1.33% | 1.07% | 5.59% | 5.81% | 11.12% |
Drawdowns
SHSAX vs. FPHAX - Drawdown Comparison
The maximum SHSAX drawdown since its inception was -39.26%, which is greater than FPHAX's maximum drawdown of -37.34%. Use the drawdown chart below to compare losses from any high point for SHSAX and FPHAX. For additional features, visit the drawdowns tool.
Volatility
SHSAX vs. FPHAX - Volatility Comparison
The current volatility for BlackRock Health Sciences Opportunities Portfolio (SHSAX) is 3.33%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 4.52%. This indicates that SHSAX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.